Form 4: Bioventus Inc. Director McMurry-Heath Reports Stock Transaction
SEC Form 4 Filing
Director Michelle McMurry-Heath reports the vesting and subsequent acquisition of 30,400 shares of Bioventus Inc. Class A Common Stock on June 7, 2024, resulting from the vesting of Restricted Stock Units.
Summary
- On June 7, 2024, Michelle McMurry-Heath, a director of Bioventus Inc., acquired 30,400 shares of Class A Common Stock.
- This acquisition resulted from the vesting of 30,400 Restricted Stock Units (RSUs).
- The RSUs vested on June 7, 2024, and each RSU represents the right to receive one share of Class A common stock.
- Following the transaction, McMurry-Heath directly owns 47,819 shares of Bioventus Inc. Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency to investors regarding the actions of company insiders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 06/07/2024 | Date of transaction: vesting of Restricted Stock Units and acquisition of Class A Common Stock. |
| 06/11/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.